Traders should monitor for imminent pricing and first-day trading activity. As a clinical-stage biopharma with no commercial revenue and a history of losses, the stock may exhibit high volatility post-IPO. Assess risk exposure given material weaknesses in internal controls and Nasdaq compliance risks noted in prior filings.
Price Chart
Executive Summary
Aspire Biopharma's IPO registration statement has become effective, allowing the company to begin selling shares to the public. This follows a prior S-1 filing and marks the transition from a private to a public company, with shares expected to start trading imminently.
Key Facts
- The S-1 registration statement for Aspire Biopharma Holdings, Inc. has become effective as of April 14, 2026.
- This is an IPO, transitioning the company from private to public.
- The effectiveness allows the company to proceed with pricing and initial trading of its shares.
- The company was previously known as PowerUp Acquisition Corp., a SPAC, before rebranding to Aspire Biopharma.
Financial Impact
Enables capital raise through IPO; exact offering size and pricing not disclosed in this filing.
Risk Factors
- Company is pre-revenue with a history of net losses
- Material weaknesses in internal controls reported
- Potential for high post-IPO volatility
- Nasdaq compliance risks previously disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001178 |
| Document: 9999999995-26-001178-index.html | 9999999995-26-001178 |
| Document: 9999999995-26-001178.txt | 9999999995-26-001178 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 20, 2026 27w ago | 8-K | $0.0200 $0.0243 | ▲ +21.50% | ▲ +14.72% | — |
Apr 16, 2026 27w ago | 8-K | $0.0200 $0.0200 | · 0.00% | ▼ −6.14% | — |
Apr 16, 2026 27w ago | 8-K | $0.0200 $0.0239 | ▲ +19.50% | ▲ +12.45% | — |
Apr 15, 2026 28w ago | EFFECT | $0.0200 $0.0200 | · 0.00% | ▼ −8.14% | — |
Apr 10, 2026 28w ago | S-1/A | $0.0200 $0.0200 | · 0.00% | ▲ +10.33% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers